311 related articles for article (PubMed ID: 6820735)
1. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.
Ohno S
Trans Ophthalmol Soc U K (1962); 1981 Sep; 101 (Pt 3)(3):335-41. PubMed ID: 6820735
[TBL] [Abstract][Full Text] [Related]
2. Immunological studies on Behçet's and Harada's diseases. I. Cell-mediated immunity in Behçet's and Harada's diseases. II. HL-A antigens associated with Behçet's disease.
Sugiura S; Sanefuji M; Ohno S
Mod Probl Ophthalmol; 1976; 16():267-78. PubMed ID: 1250232
[TBL] [Abstract][Full Text] [Related]
3. The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.
Lehner T; Welsh KI; Batchelor JR
Immunology; 1982 Dec; 47(4):581-7. PubMed ID: 6958639
[TBL] [Abstract][Full Text] [Related]
4. Behçet's disease and streptococcal infection.
Namba K; Ueno T; Okita M
Jpn J Ophthalmol; 1986; 30(4):385-401. PubMed ID: 3586405
[TBL] [Abstract][Full Text] [Related]
5. HLA antigens and Vogt-Koyanagi-Harada's disease.
Yu Q; Mao W; Xie C; Li S
Yan Ke Xue Bao; 1991 Mar; 7(1):3-5. PubMed ID: 1726860
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of Vogt-Koyanagi-Harada's disease and its association with HLA].
Zhao M
Zhonghua Yan Ke Za Zhi; 1992 Jan; 28(1):40-3. PubMed ID: 1499433
[TBL] [Abstract][Full Text] [Related]
7. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.
Kitaichi N; Kotake S; Sasamoto Y; Namba K; Matsuda A; Ogasawara K; Onoé K; Matsuda H; Nishihira J
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):247-50. PubMed ID: 9888451
[TBL] [Abstract][Full Text] [Related]
8. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
El-Asrar AM; Struyf S; Kangave D; Al-Obeidan SS; Opdenakker G; Geboes K; Van Damme J
Clin Immunol; 2011 May; 139(2):177-84. PubMed ID: 21334264
[TBL] [Abstract][Full Text] [Related]
9. Requirement of Ia-positive nylon wool adherent cells for activation of cytotoxic T-lymphocytes specific to melanocyte-associated antigens in patients with Vogt-Koyanage-Harada's disease.
Maezawa N; Yano A
Jpn J Ophthalmol; 1988; 32(3):348-57. PubMed ID: 3265967
[TBL] [Abstract][Full Text] [Related]
10. [Immunogenetic and molecular genetic studies on ocular diseases].
Ohno S
Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1558-79. PubMed ID: 1362479
[TBL] [Abstract][Full Text] [Related]
11. HLA antigens and certain types of uveitis.
Crews SJ; Mackintosh P; Barry DR; Willshaw HE
Trans Ophthalmol Soc U K (1962); 1979 Apr; 99(1):156-9. PubMed ID: 297369
[TBL] [Abstract][Full Text] [Related]
12. HLA class II genes in Vogt-Koyanagi-Harada disease.
Islam SM; Numaga J; Fujino Y; Hirata R; Matsuki K; Maeda H; Masuda K
Invest Ophthalmol Vis Sci; 1994 Oct; 35(11):3890-6. PubMed ID: 7928186
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Behçet's disease in a Chinese Han population.
Shu Q; Yang P; Hou S; Li F; Chen Y; Du L; Jiang Z
Hum Immunol; 2010 Oct; 71(10):988-91. PubMed ID: 20620187
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immunogenetic investigation of a Laotian patient with Vogt-Koyanagi-Harada's disease.
Shindo Y; Inoko H; Nakamura S; Onoe K; Inoue T; Ohno S
Ophthalmologica; 1996; 210(2):112-4. PubMed ID: 9148256
[TBL] [Abstract][Full Text] [Related]
15. Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease.
Otani S; Sakurai T; Yamamoto K; Fujita T; Matsuzaki Y; Goto Y; Ando Y; Suzuki S; Usui M; Takeuchi M; Kawakami Y
Br J Ophthalmol; 2006 Jun; 90(6):773-7. PubMed ID: 16481377
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California.
Levinson RD; See RF; Rajalingam R; Reed EF; Park MS; Rao NA; Holland GN
Hum Immunol; 2004 Dec; 65(12):1477-82. PubMed ID: 15603876
[TBL] [Abstract][Full Text] [Related]
17. [Behçet's disease and HLA antigens--an association with a new specificity recognized by a monoclonal antibody].
Nakayama T
Hokkaido Igaku Zasshi; 1985 Sep; 60(5):643-52. PubMed ID: 2416665
[TBL] [Abstract][Full Text] [Related]
18. [Behçet's disease and class II and III antigens of the major histocompatibility complex].
Hamza M; Ayed K; Bardi R; Gorgi Y; Meddeb N
Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):59-61. PubMed ID: 2320926
[No Abstract] [Full Text] [Related]
19. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
Damico FM; Cunha-Neto E; Goldberg AC; Iwai LK; Marin ML; Hammer J; Kalil J; Yamamoto JH
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
[TBL] [Abstract][Full Text] [Related]
20. Harada's, Behcet's, Vogt-Koyanagi syndromes--are they clinical entities?
Shimizu K
Trans Am Acad Ophthalmol Otolaryngol; 1973; 77(3):OP281-90. PubMed ID: 4731490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
